Twelve patients (6 males, 6 females; aged 31-81 years, with metastatic
tumors underwent prevention and treatment of
seroma with the tissue flaps and
Arista hemostatic powder spray after regional lymph node resection. The metastatic
tumors involved the axilla in 1 patient with
breast carcinoma, the iliac and inguinal regions in 2 patients with
carcinomas of the uterine cervix and the rectum, and the inguinal region in 9 patients, including 4 patients with
malignant fibrous histiocytoma(3 in the thigh, 1 in the leg), 2 patients with
squamous carcinomas in the leg, 1 patient with
synovial sarcoma in the knee, 1 patient with
epithelioid sarcoma in the leg, and 1 patient with
malignant melanoma in the foot. As for the lymph node removal
therapy. 1 patient underwent axillary lymph node removal, 2 patients underwent lymph node removal in theiliac and inguinal regions, and 9 patients underwent lymph node removal in the inguinal region. Meanwhile, of the 12 patients, 6 patients underwent transposition of sartorius flaps with
Arista hemostatic powder, 3 patients underwent transposition of the rectus abdominis
myocutaneous flaps (including 2 patients treated with
Arista spray befor the
wound closure and 1 patient treated by transposition of local skin flaps with
Arista spray used again),and 3 patients underwent only the suturing of the
wounds combined with
Arista. At the same time, of the 12 patients,only 4 patient underwent the
transplantation of
artificial blood vessels.
RESULTS: The follow-up for 2-10 months after operation revealed that 10 patients, who had received the transposition of tissue flaps and the spray of
Arista hemostatic powder, had the first intention of the incision heal with
seroma cured. Nine patients were given a preventive use of
Arista hemostatic powder and therefore no
seroma developed. The combined use of the transposition of tissue flaps and
Arista hemostatic powder spray achieved a success rate of 100% in the prevention or treatment of
seroma. However, 1 patient developed microcirculation disturbance 24 hours after operation and underwent
disarticulation of the hip; 1 patient developed pelvic cavity
hydrops and died 10 months after operation.
CONCLUSION: